Clinical Trial Update: Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics and safety of ticarcillin-clavulanate in infants for sepsis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Ticarcillin/Clavulanate (Ticarcillin/clavulanate)

Snippet

Sponsor: Phillip Brian Smith | Conditions: Sepsis | Phase 1 | Status: WITHDRAWN